Free Trial

Alto Neuroscience (ANRO) SEC Filings & 10K Form

Alto Neuroscience logo
$1.80 -0.05 (-2.43%)
Closing price 03:58 PM Eastern
Extended Trading
$1.80 0.00 (-0.28%)
As of 06:39 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Alto Neuroscience SEC Filings

DateFilerForm TypeView
04/01/2025
3:25 PM
Alto Neuroscience (Filer)
Form ARS
03/20/2025
4:15 PM
Alto Neuroscience (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/20/2025
3:32 PM
Alto Neuroscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/20/2025
3:36 PM
Alto Neuroscience (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2025
5:26 PM
Alto Neuroscience (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SCHEDULE 13G/A
02/12/2025
7:16 AM
Alto Neuroscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/11/2025
11:15 PM
Alto Neuroscience (Filer)
Form EFFECT
02/03/2025
3:39 PM
Alto Neuroscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/03/2025
3:07 PM
Alto Neuroscience (Filer)
Form S-3
Registration statement under Securities Act of 1933  
01/16/2025
6:00 AM
Alto Neuroscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
4:46 PM
Alto Neuroscience (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13G/A
11/14/2024
6:00 AM
Alto Neuroscience (Subject)
Etkin Amit (Filed by)
Form SC 13G
10/22/2024
3:35 PM
Alto Neuroscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/21/2024
3:11 PM
Alto Neuroscience (Subject)
BlackRock, Inc. (Filed by)
Form SC 13G
08/13/2024
3:33 PM
Alto Neuroscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
3:36 PM
Alto Neuroscience (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/29/2024
3:19 PM
Alto Neuroscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/22/2024
4:19 PM
Alto Neuroscience (Issuer)
Hanley Jr. Michael Conick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
7:29 AM
Alto Neuroscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NYSE:ANRO) was last updated on 4/4/2025 by MarketBeat.com Staff
From Our Partners